Best GLP-1 Online Programs: Top Telehealth Providers Compared (2026)

For informational purposes only—not medical advice.
The best GLP-1 online programs let you talk to a licensed clinician, get a clear price, and start fast — no waiting rooms, no “no prescription needed” scams, no surprise fees. We compared over 30 telehealth GLP-1 programs on real monthly cost, medication type, clinical support, and who each one actually fits. Then we cut the list to eight.
Here is the short version: for most self-pay readers, Embody is the strongest place to start in 2026. It has the lowest first-month price on our list ($99 for compounded semaglutide injection), the only needle-free GLP-1 gum option we have found anywhere, 24/7 support, HSA/FSA acceptance, and a full refund if a licensed provider decides you do not medically qualify. If you want FDA-approved brand-name medication — or you want help getting insurance to pay — Ro is the better path ($39 first month, then membership from as low as $74/month with an annual plan, plus a free insurance coverage checker). And if a long public track record matters most to you, MEDVi still has the largest review base in this category by far.
But the cheapest first month is not the whole story. Below, we show you exactly what each program costs after month one, which programs received FDA warning letters this year, and who should skip our top pick entirely. If you have been stuck with fifteen browser tabs open, this page is built to close them.
Affiliate Disclosure: Some providers on this page are affiliate partners. This does not affect our rankings or analysis. We have declined to feature providers that did not meet our standards, including some that offered partnerships.
The Short Answer — Which GLP-1 Online Program Is Best?
No single program is best for everyone. The right pick depends on three things: whether you want FDA-approved brand-name medication or are open to compounded options, whether you are paying cash or using insurance, and whether you are okay with weekly injections or want to avoid needles entirely. For most cash-pay readers open to compounded medication, Embody is the strongest starting point in 2026; for brand-name medication and insurance help, Ro leads; for the longest public track record, MEDVi.
Here is how we sort it:
Embody
Embody earns our top self-pay spot for a simple reason: it removes the two biggest barriers people tell us about — price to start and needles. The first month of compounded semaglutide injection is $99 — the lowest entry price on this list. After month one, standard refills run $299/month, and Embody also lists flat-pricing plans from $199/month. Tirzepatide injection starts at $149 month one (then $399/month).
The bigger differentiator is the needle-free GLP-1 gum — one piece per day, prescribed by a licensed clinician, and the only gum-format GLP-1 we have found at any telehealth program. Semaglutide gum: $149 month one (then $349/month). Everything is cash-pay, HSA/FSA is accepted at checkout, support is 24/7, and if a provider decides you are not medically eligible, Embody’s policy is a full refund for medication not dispensed.
Check current eligibility, pricing, and availability in your state
Compounded medications are not FDA-approved. Not available in Mississippi or Louisiana.

Embody
GLP-1 Weight Loss Program
Best FDA-approved brand-name route — Ro.
If you want brand-name medication — Wegovy, Zepbound, or Foundayo — or you want someone to fight the insurance battle for you, start with Ro. Ro carries Foundayo™ (orforglipron tablets), Wegovy® pill, Wegovy® pen, Zepbound® pen, and Zepbound® KwikPen, matches manufacturer self-pay pricing, and includes a free GLP-1 Insurance Coverage Checker plus an insurance concierge that handles prior-authorization paperwork for you. Membership is $39 first month, then $149/month (or as low as $74/month annual).
Most established compounded program (largest review base) — MEDVi.
MEDVi remains the most-reviewed compounded GLP-1 program we track: 4.4/5 from 11,498 Trustpilot reviews as of June 2026. Compounded plans start at $179 month one (then $299/month) with 24/7 support and unlimited appointments. If a large independent track record is what lets you sleep at night, this is your pick. One important caveat: MEDVi received an FDA warning letter in February 2026 — we explain what that means in the full review.
Best mainstream brand-name platforms — Hims / Hers.
Hims and Hers announced a March 2026 collaboration with Novo Nordisk to carry branded semaglutide medicines, including Wegovy. If you want a familiar, mainstream telehealth brand with a clean brand-name-first route, start here.
Best needle-free compounded tablets — Willow.
Willow emphasizes compounded oral semaglutide tablets and same-day clinician review. If you want a daily tablet instead of a weekly shot (and the gum is not your thing), Willow is worth a look.
Best budget alternatives — TrimRx and SkinnyRx.
Lower entry pricing for cost-conscious users who want compounded GLP-1 access without extra layers.
Not sure which path fits? Keep reading — the comparison table, full reviews, and our free 60-second matching quiz will make it clear.
Which GLP-1 Program Fits Your Situation?
There are three ways to get GLP-1 medication online in 2026 — FDA-approved brand-name, compounded, and needle-free oral formats — and they come with very different prices and rules. Pick your route first, then your provider.
Route 1: FDA-approved brand-name medication.
FDA-approved brand-name GLP-1 options for weight loss include Wegovy (semaglutide injection and tablets, by Novo Nordisk), Zepbound (tirzepatide injection, by Eli Lilly), Foundayo (orforglipron tablets, by Eli Lilly), and Saxenda (liraglutide injection, by Novo Nordisk). Ozempic and Mounjaro are FDA-approved for type 2 diabetes and may be prescribed off-label for weight loss. Oral Wegovy starts at $149/month self-pay for the 1.5 mg and 4 mg doses (the 4 mg dose rises to $199/month after August 31, 2026; the 9 mg and 25 mg doses are $299/month). Providers on our list with FDA-approved brand-name access: Ro (broadest branded menu plus insurance concierge), Hims, Hers. MEDVi also currently lists branded Wegovy and Zepbound paths.
Route 2: Compounded GLP-1 medication.
Compounded versions of semaglutide and tirzepatide are prepared by licensed U.S. compounding pharmacies under a clinician’s prescription. They are not FDA-approved as finished products. The FDA does not review them for safety, effectiveness, or quality before they reach you. They are also not the same as generic drugs. Compounded products on this list run $99 to $449 per month depending on medication, format, and whether it is intro or ongoing pricing. Providers on our list with compounded programs: Embody, MEDVi, TrimRx, SkinnyRx, Willow.
Route 3: Needle-free GLP-1 (no injections).
Three needle-free paths now exist: (1) FDA-approved oral Wegovy (semaglutide tablets) — from $149/month self-pay, available through Ro and Hims/Hers via Novo Nordisk collaboration. (2) FDA-approved Foundayo (orforglipron tablets) — Eli Lilly’s oral option, available through Ro. (3) Compounded oral formats — Embody’s GLP-1 gum (one piece per day, from $149 month one) and compounded tablets from Willow and MEDVi. These are not FDA-approved and are not the same product as oral Wegovy or Foundayo. If needles were your dealbreaker, 2026 is the year that excuse expired.
A note on the current regulatory climate
On March 3, 2026, the FDA announced 30 warning letters (sent February 20) to telehealth companies for making misleading claims about compounded GLP-1 products — mostly implying their products were equivalent to FDA-approved drugs, or hiding where the medication was actually made. This does not mean compounded GLP-1 programs are illegal. It means the FDA is holding companies to a higher standard of honesty. On this page, every provider is clearly labeled as brand-name, compounded, or both. Providers on this list that received warning letters: MEDVi (February 2026), Willow (March 2026 wave), SkinnyRx (early 2026). Providers that did not appear in the FDA’s published letters as of our June 2026 check: Embody, Ro, TrimRx.
Quick-match: find your row —
| If you want… | Your best fit | Why |
|---|---|---|
| The cheapest way to start, self-pay | Embody | $99 first month semaglutide injection — lowest on this list |
| A needle-free option without a daily pill | Embody | The only GLP-1 gum we have found; one piece per day, from $149 month one |
| FDA-approved brand-name medication | Ro | Foundayo, Wegovy pill/pen, Zepbound pen/KwikPen at manufacturer-matched prices |
| Help getting insurance to cover it | Ro | Insurance concierge handles prior auth; free coverage checker |
| The biggest review track record | MEDVi | 4.4/5 from 11,498 Trustpilot reviews |
| A familiar mainstream brand | Hims or Hers | Branded Wegovy via Novo Nordisk collaboration |
| A daily compounded tablet | Willow | Oral-first positioning, same-day clinician review |
| The lowest-frills budget route | TrimRx or SkinnyRx | Lean compounded programs, minimal extras |
| Not sure — still deciding | Take our 60-second quiz | We will match you to the right fit |
Found your row? See Embody’s current pricing if it pointed there — or keep reading for the full side-by-side.
GLP-1 Online Programs Compared: Pricing, Support, and Trust Signals
Data verified June 12, 2026. We re-check pricing, pharmacy status, and review scores monthly. How to use this table: find the column that matters most to you and compare across rows. Every provider includes a link to verify current details on their site.
| Embody ⭐ | MEDVi | Ro | Hims | Hers | Willow | TrimRx | SkinnyRx | |
|---|---|---|---|---|---|---|---|---|
| Best for | Lowest-cost start + needle-free gum | Largest review base | Brand-name + insurance help | Brand-name (men) | Brand-name (women) | Needle-free tablets | No-frills access | Budget |
| Medication type | Compounded semaglutide & tirzepatide (injection or gum) | Compounded core + branded Wegovy/Zepbound paths listed | FDA-approved brand-name only (Foundayo, Wegovy, Zepbound) | Brand-name + compounded | Brand-name + compounded | Compounded (oral emphasis) | Compounded | Compounded |
| Month 1 price | $99 (sema injection); $149 (sema gum or tirz injection); $199 (tirz gum) | $179 compounded; branded $99 membership + medication | $39 membership + medication (oral Wegovy from $149/mo) | Varies by med | Varies by med | Verify on site | Verify on site | Verify on site |
| Ongoing price | $299–$449/mo by med/format; flat plans from $199/mo | $299/mo compounded | $149/mo membership (as low as $74/mo annual) + medication | Varies | Varies | Verify on site | Verify on site | Verify on site |
| Needle-free option? | Yes — GLP-1 gum (only gum format on this list) | Compounded tablets + branded Wegovy pill listed | Yes — Wegovy tablets, Foundayo tablets (FDA-approved) | Branded Wegovy pill (verify) | Branded Wegovy pill (verify) | Yes — compounded tablets | No | No |
| Insurance | No — cash-pay only | Cash-pay focus | Yes — concierge + free coverage checker | Varies | Varies | No | No | No |
| HSA/FSA | Yes, accepted at checkout | Generally eligible — verify | Generally eligible — verify | Verify | Verify | Verify | Verify | Verify |
| Refund policy | Full refund if provider disqualifies you | Cancel 72+ hrs before billing | Verify on site | Verify | Verify | Verify | Verify | Verify |
| Trustpilot | 3.1/5 from 82 reviews (newer, small sample) | 4.4/5 from 11,498 reviews | See site | See site | See site | See site | See site | See site |
| FDA warning letter (2025–26)? | Not in published letters as of June 2026 | Yes — Feb 2026 (marketing claims) | No | Sept 2025 scrutiny; pivoted to branded | Same as Hims | Yes — March 2026 wave | Not in published letters | Yes — early 2026 |
| Support | 24/7 messaging + care team | 24/7 support + unlimited appointments | Messaging + insurance concierge | Messaging | Messaging | Same-day review | Messaging | Basic messaging |
| Pharmacy sourcing | U.S.-based 503A compounding pharmacies | Licensed U.S. compounding pharmacies | Brand manufacturers | Manufacturer + compounding | Manufacturer + compounding | Licensed U.S. compounding pharmacies | Verify on site | Verify on site |
| Links | Check Embody | Check MEDVi | View Ro | View Hims | View Hers | Explore Willow | See TrimRx | See SkinnyRx |
Every provider on this list states that it uses U.S.-licensed clinicians. We excluded programs with deceptive pricing, no real clinical oversight, or marketing that misrepresented medication type.
Every program’s cheapest published first month, ranked:
| Rank | Program | Cheapest published month 1 | What it gets you |
|---|---|---|---|
| 1 | Embody | $99 | Compounded semaglutide injection, consult, support, shipping if approved |
| 2 | Ro | $39 membership (medication billed separately — oral Wegovy from $149/mo) | Brand-name access + insurance concierge |
| 3 | Embody (gum/tirz) | $149 | Semaglutide gum or tirzepatide injection |
| 4 | MEDVi | $179 | Compounded program, all-in |
| 5 | Hims / Hers / Willow / TrimRx / SkinnyRx | Varies — verify on site | Mixed |
The honest read: Ro’s $39 looks lowest, but it is a membership fee — medication is billed on top. Embody’s $99 is the lowest all-in first month that includes the medication itself. Most comparison pages blur this distinction.
Want the all-in $99 start?
Check availability in your stateWhat Changed in the GLP-1 Market in 2026 — and Why It Matters
Five things changed in 2026 that directly affect which program you should pick.
Oral Wegovy launched.
For the first time, there is an FDA-approved GLP-1 weight-loss pill. Self-pay pricing under Novo Nordisk’s program starts at $149/month for the 1.5 mg dose. A genuine game-changer for needle-averse patients who want the FDA-approved route.
The FDA intensified enforcement.
On March 3, 2026, the FDA announced 30 warning letters to telehealth companies over misleading compounded-GLP-1 marketing. Among providers on this page: MEDVi (February 2026), Willow (March 2026 wave), and SkinnyRx (early 2026) received letters. Embody, Ro, and TrimRx did not appear in the FDA’s published letters as of our June 2026 check.
Hims & Hers partnered with Novo Nordisk.
Announced March 9, 2026 — Hims and Hers now offer Novo Nordisk’s branded semaglutide medicines while scaling back compounded GLP-1 marketing.
Medicare GLP-1 coverage starts July 1, 2026.
The Medicare GLP-1 Bridge is a time-limited CMS demonstration covering Foundayo, Wegovy injection/tablets, and Zepbound KwikPen for eligible Part D beneficiaries at a $50 monthly copay, running through December 31, 2027. Compounded programs do not participate.
Brand-name prices are dropping — slowly.
Oral Wegovy, Zepbound vials, and manufacturer programs have narrowed the gap. But brand-name at full dose still costs significantly more than compounded alternatives for most cash payers.
Why our top pick changed — and what that says about how we work
Earlier this year, MEDVi held our #1 self-pay spot, mostly on the strength of its review volume and all-in pricing. When we re-verified every program in June 2026, Embody now offers the lowest all-in first month ($99 vs. MEDVi’s $179), the only needle-free gum format in the category, HSA/FSA at checkout, a refund-if-disqualified policy, and — unlike MEDVi — it has not appeared in the FDA’s published warning letters. MEDVi did not get worse. It is still the most-reviewed program here, and for some readers that track record will rightly win. But “best place to start for most self-pay readers” now points to Embody — and we would rather update a ranking than defend a stale one.
Full Reviews of the Best GLP-1 Online Programs
We use the same template for every provider so you can compare apples to apples: bottom line, quick facts, what we like, what to watch, and who it is (and is not) for.
Embody Review: Best Low-Cost Start and the Only Needle-Free GLP-1 Gum
Bottom line: Embody (run by Modern Metabolic Medicine, Inc.) is a cash-pay telehealth GLP-1 program built for people who want fast online access, the lowest starting price in the category, and a choice between weekly injections and a needle-free GLP-1 gum. If a licensed provider decides treatment is appropriate, compounded semaglutide or tirzepatide ships to your door, with 24/7 support included. It is our top pick for most self-pay readers in 2026 — with one honest caveat we will get to in a moment.
Quick facts:
- Month 1 pricing (Start Program): semaglutide injection $99 · semaglutide gum $149 · tirzepatide injection $149 · tirzepatide gum $199
- Ongoing pricing: $299/month (sema injection) · $349 (sema gum) · $399 (tirz injection) · $449 (tirz gum). Flat-pricing plans from $199/month for semaglutide injection
- Medications: Compounded semaglutide and tirzepatide — weekly injections or daily gum. Compounded products are not FDA-approved.
- Payment: Cash-pay only; no insurance billing. HSA/FSA accepted at checkout
- Intake: Quick online questionnaire; medical practitioner typically reviews within 24 hours
- Pharmacy: U.S.-based 503A compounding pharmacies
- Support: 24/7 messaging, ongoing care-team guidance, clinician oversight, dose adjustments as needed
- Refunds: Full refund if the medical provider determines you are not medically eligible (for medication not dispensed)
- Availability: Broad U.S. — Mississippi and Louisiana currently excluded per Embody’s FAQ
- Trustpilot: 3.1/5 from 82 reviews as of June 2026
The one thing you should know before anything else:
Embody does not have a long public track record. Its Trustpilot profile shows a 3.1/5 rating from just 82 reviews as of June 2026 — a small, mixed early sample — and the “4.8” badge on Embody’s own landing pages does not match that independent score. The most common complaints in early reviews involve refill shipping delays and billing friction. If a 10,000-review history is your deciding factor, MEDVi is the better pick, full stop. But here is the flip side: because Embody is the newer, leaner program, it charges the lowest all-in first month on this list ($99), it is the only program anywhere offering a GLP-1 gum, and it backs intake with a full refund if a provider says you do not qualify. New program, real tradeoff, real upside. You now know both.
What we like:
What to watch out for:
The $99 is intro pricing — standard refills run $299/month for semaglutide injection and up to $449/month for tirzepatide gum, so budget for the ongoing rate, not the promo. Embody’s shipped products are compounded, which means the FDA has not reviewed them for safety, effectiveness, or quality. There is no insurance billing of any kind. Some early Trustpilot reviews report refill shipping delays — if a late dose would seriously stress you, ask support about refill timing before you commit. Confirm your state during intake; Mississippi and Louisiana are currently excluded.
Best for: Self-pay adults who want the lowest-cost legitimate way to start GLP-1 treatment, needle-averse people who want the gum option, and anyone using HSA/FSA dollars without insurance.
Not best for: People who want FDA-approved brand-name medication (go to Ro), insurance billing (Ro), or a long-established review track record (MEDVi).
Embody — #1 Pick, June 2026
Compounded semaglutide injection from $99 month one (then $299/mo; flat plans from $199/mo) · Needle-free GLP-1 gum from $149 month one · 24/7 support · HSA/FSA accepted · Full refund if you do not medically qualify
See If You Qualify for Embody →A licensed provider reviews every intake — typically within 24 hours
MEDVi Review: Most Established Compounded GLP-1 Program
Bottom line: MEDVi is the most-reviewed compounded GLP-1 program we track — 4.4/5 from 11,498 Trustpilot reviews as of June 2026 — with all-in compounded pricing from $179 month one, 24/7 support, and unlimited appointments. Its product pages now also list branded Wegovy and Zepbound paths, making it more of a hybrid than a compounded-only shop. If a large independent track record is what lets you sleep at night, this is your pick.
Quick facts:
- Monthly cost: Compounded path $179 month one, then $299/month; branded paths shown separately as $99 membership + medication
- Medications: Compounded semaglutide and tirzepatide (injections and tablets); product navigation also shows Wegovy pill, Wegovy injection, and Zepbound injection, marked subject to availability
- Support: 24/7 support + unlimited appointments
- Clinician network: OpenLoop Health (licensed U.S. physicians)
- Cancellation: Cancel at least 72 hours before your next billing date
- Trustpilot: 4.4/5 from 11,498 reviews as of June 2026
What we like:
The review volume is the headline. 11,498 reviews at 4.4 gives you far more signal than a provider with 82 reviews — you can read thousands of real experiences, good and bad, before you spend a dollar. The compounded all-in pricing model is also still strong: consult, medication, shipping, and support in one number, with no separate membership fee on the compounded path.
What to watch out for:
MEDVi received an FDA warning letter on February 20, 2026, related to marketing claims about its compounded products — part of the industry-wide wave that reached 30 companies by March. The FDA’s concern was marketing language implying compounded products are equivalent to FDA-approved drugs — not a finding that the program is unsafe or illegal. But if regulatory standing is high on your list, that letter is a real mark against MEDVi that Embody and Ro do not currently carry. Also: MEDVi’s $179 entry is $80 more than Embody’s, the ongoing rate is the same $299, and some reviewers mention billing friction around cancellations.
Best for: Self-pay users who want the largest review track record in compounded GLP-1 care and the option to explore branded paths inside one ecosystem.
Not best for: People prioritizing the lowest entry price or a clean regulatory record — Embody currently wins both.
Check MEDVi’s current pricing and availabilityRo Review: Best FDA-Approved Brand-Name Route (and Best for Insurance)
Bottom line: Ro is the cleanest path on this list to FDA-approved brand-name GLP-1 medication. It carries Foundayo™ (orforglipron), Wegovy® pill, Wegovy® pen, Zepbound® pen, and Zepbound® KwikPen, matches LillyDirect / NovoCare self-pay pricing on medication, and — uniquely on this list — includes an insurance concierge that handles prior-authorization paperwork for you, plus a free GLP-1 Insurance Coverage Checker you can run before spending anything.
Quick facts:
- Membership: $39 first month, then $149/month — or as low as $74/month with an annual plan paid upfront
- Medication cost: Billed separately at manufacturer-matched self-pay prices (oral Wegovy from $149/month) — or your insurance copay if covered
- Medications: FDA-approved brand-name only: Foundayo, Wegovy pill and pen, Zepbound pen and KwikPen
- Insurance: Concierge handles prior authorizations; free coverage checker
- Support: Messaging-based clinician access
What we like:
If you have insurance that might cover a GLP-1, Ro is the only program here that does the annoying part for you. Prior authorization is the wall most people hit; Ro’s concierge climbs it. And for cash payers who simply want the FDA-approved product, manufacturer-matched pricing means you are not paying a telehealth markup on the medication itself.
What to watch out for:
The membership fee is on top of medication cost, so your true monthly total is membership + medication (or copay). Brand-name medication at higher doses still costs more than compounded programs. And Ro is not the place for compounded or needle-free compounded options — that is not its lane.
Best for: Anyone who wants FDA-approved medication, anyone with insurance worth checking, and Medicare beneficiaries preparing for the July 1 Bridge program.
Not best for: Budget-first cash payers open to compounded medication — Embody’s $99 start will beat Ro’s all-in math for most of them.
Hims Review: Best Brand-Name Platform for Men
Bottom line: Hims is a major consumer telehealth platform that announced a March 2026 collaboration with Novo Nordisk to offer branded semaglutide medicines, including Wegovy. If you want FDA-approved medication through a mainstream brand you already recognize, Hims is a clear path.
What we like:
The Novo Nordisk collaboration means Hims offers branded semaglutide through a legitimate manufacturer relationship, with a polished app and simple onboarding. Hims faced FDA scrutiny in September 2025 over compounded GLP-1 marketing; the Novo deal represents a clean pivot toward branded products.
What to watch out for:
Brand-name pricing varies significantly by medication and dose — understand the full cost before checkout. GLP-1 options on Hims are not yet available in all 50 states. And Hims does not offer Ro’s insurance concierge, so if coverage is your goal, Ro works harder for you.
Best for: Men who want FDA-approved brand-name medication through a mainstream platform.
Not best for: Budget-focused self-pay users — brand-name pricing runs well above compounded alternatives.
View Hims GLP-1 optionsHers Review: Best Brand-Name Platform for Women
Bottom line: Hers is the women’s counterpart to Hims — same infrastructure, same Novo Nordisk collaboration for branded Wegovy access, with intake and content tailored to women’s health.
What we like:
Mainstream scale, brand recognition, and direct branded access, in a platform designed for women.
What to watch out for:
Same pricing considerations as Hims, same not-yet-all-50-states limitation, same lack of an insurance concierge. Verify what you are paying for before you start.
Best for: Women who want a women-focused platform with brand-name FDA-approved medication.
Not best for: Budget-first users looking for the lowest compounded price — that is Embody’s lane.
View Hers GLP-1 optionsWillow Review: Best for Needle-Free Compounded Tablets
Bottom line: Willow positions itself around compounded oral semaglutide tablets and a no-needle philosophy, with same-day clinician review. If you want a daily tablet rather than a weekly shot — and the gum format is not for you — Willow removes the needle barrier.
What we like:
Oral-first positioning solves a real problem, and same-day clinician review means fast time to treatment, with no long-term commitment.
What to watch out for:
Willow Health Services was named in the March 2026 FDA warning-letter wave over compounded-GLP-1 marketing claims, and received a December 2025 National Advertising Division recommendation to modify certain health claims for its semaglutide tablets. Its tablets are compounded, not FDA-approved. If you specifically want the FDA-approved oral pill, that is oral Wegovy or Foundayo — through Ro, or Hims/Hers.
Best for: People who want a daily compounded tablet and fast clinician review.
Not best for: People who want FDA-approved oral medication (Ro) or the gum format (Embody).
Explore Willow’s oral optionsTrimRx Review: Best for Straightforward Medication Access
Bottom line: TrimRx focuses on what many people actually want: affordable compounded GLP-1 medication without coaching programs, community features, or membership layers they will never use. Clean, direct, no extras.
What we like:
The simplicity. You pay for medication and clinical oversight, not features you will not touch. No long-term commitment, and TrimRx has not appeared in the FDA’s published warning letters as of our June 2026 check.
What to watch out for:
Less support infrastructure than Embody or MEDVi — no 24/7 messaging. We have also seen billing and cancellation complaints in reviews, so read the cancellation terms before you start. You are trading support for savings; make sure that trade works for you.
Best for: Self-motivated users who want lean, affordable compounded access.
Not best for: People who want high-touch support, the gum format, or extensive check-ins.
See TrimRx plans and pricingSkinnyRx Review: Lean Budget Compounded Option
Bottom line: SkinnyRx competes on price. If your single priority is a low monthly cost for compounded GLP-1 medication with licensed clinician oversight, SkinnyRx is built for that lane.
What we like:
The price. Over six months of treatment, small monthly differences add up to real money. SkinnyRx keeps costs down by keeping the program lean.
What to watch out for:
SkinnyRx received an FDA warning letter in early 2026 regarding compounded-GLP-1 marketing claims, as part of the industry-wide enforcement wave. Its products are compounded, not FDA-approved. Lean also means leaner support — response times may be slower than 24/7 programs, which matters if you hit side effects mid-titration. For a similar entry price with stronger support and a cleaner regulatory record, compare Embody’s $99 first month before you decide.
Best for: Budget-first users who have compared the leading options and prefer SkinnyRx’s pricing.
Not best for: Anyone who wants strong support or the most reassuring trust signals.
View SkinnyRx current pricingHonest Tradeoffs — Who Should Skip Each Option?
Every program on this list has at least one real limitation. The fastest way to choose well is to find your dealbreaker first.
| Provider | Skip this if… | Better alternative |
|---|---|---|
| Embody | You want brand-name medication, insurance billing, or a long-established review history | Ro (brand/insurance) · MEDVi (track record) |
| MEDVi | The Feb 2026 FDA warning letter or the $179 entry price bothers you | Embody |
| Ro | You are cash-pay and brand-name math does not fit your budget | Embody |
| Hims / Hers | Budget is your primary concern, or you want insurance handled for you | Embody (budget) · Ro (insurance) |
| Willow | You want FDA-approved oral medication, or its FDA/NAD history concerns you | Ro |
| TrimRx | You need 24/7 support or careful billing terms | Embody or MEDVi |
| SkinnyRx | You want stronger trust signals or real support | Embody or MEDVi |
This section exists because most “best of” pages skip it. Telling you who each program is not for builds more trust than pretending everyone fits everything.
Brand-Name vs. Compounded GLP-1s: The Decision You Need to Make First
Brand-name (FDA-approved) means Wegovy and Zepbound for weight loss, made by Novo Nordisk and Eli Lilly, plus Foundayo (orforglipron) and Saxenda. Fully reviewed by the FDA. This is the gold standard for regulatory certainty. Self-pay pricing varies: oral Wegovy from $149/month at lower doses; injectable brand-name can run substantially higher. On this list: Ro (broadest branded menu plus insurance help), Hims, Hers, and MEDVi’s listed branded paths.
Compounded means a licensed U.S. compounding pharmacy prepares semaglutide or tirzepatide under a clinician’s prescription. These products are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality before they reach you. Monthly cost: typically $99–$449 depending on medication, format, and intro vs. ongoing pricing. On this list: Embody, MEDVi, TrimRx, SkinnyRx, Willow.
What to avoid entirely: Products sold without a prescription, anything labeled “research use only,” GLP-1 products from overseas or unregulated sellers, and any provider that guarantees approval before a clinician evaluates you.
How to decide: If you have insurance that might cover a GLP-1, check that first — run Ro’s free coverage checker and let the concierge handle prior auth, because a covered brand-name prescription beats every cash price on this page. If you are paying cash and brand-name math does not fit your budget, a reputable compounded program is a legitimate alternative — and Embody’s $99 first month is the cheapest honest way to start. The worst option is doing nothing because the choices feel overwhelming.
What Do GLP-1 Programs Actually Cost? The Fees Pages Don’t Mention
The advertised price is almost never the price you end up paying. The four costs that catch people:
The intro-pricing reality. Most programs lead with a discounted first month. Embody’s $99 becomes $299/month at standard refill. MEDVi’s $179 becomes $299. Always ask: what will I pay at my maintenance dose after the promo ends? Embody also lists flat plans from $199/month if you want one locked number.
Membership vs. all-in. Ro charges $39 then $149/month membership, with medication billed separately at manufacturer-matched prices. Embody and MEDVi’s compounded plans are all-in (consult + medication + shipping + support in one number). Compare totals, not headlines.
Dose escalation. Some programs raise prices at higher doses. Confirm your maintenance-dose price before you start.
Other line items. Consult fees ($0 at all-in programs; $49–$99 elsewhere), shipping (usually free — verify), optional labs ($0–$150), optional coaching ($25–$149/month), and cancellation notice (typically 48–72 hours before billing; MEDVi requires 72).
What your first 90 days actually costs (our math, in one place):
| Path | Month 1 | Months 2–3 | 90-day total (est.) |
|---|---|---|---|
| Embody — sema injection (Start) | $99 | $299 × 2 | ~$697 |
| Embody — sema injection (Flat plan) | from $199 | from $199 × 2 | from ~$597 (verify bundle terms) |
| MEDVi — compounded | $179 | $299 × 2 | ~$777 |
| Ro + oral Wegovy (cash) | $39 + $149 med | ($149 + $149) × 2 | ~$784 |
| Embody — tirzepatide injection | $149 | $399 × 2 | ~$947 |
| Hims / Hers (branded) | Varies | Varies by med + dose | Verify on site |
Estimates from published pricing as of June 2026. Insurance coverage can cut the Ro medication line to a copay. Verify current pricing with each provider before you commit.
Nobody else publishes this table — most pages compare month-one prices and stop, which is exactly how people end up surprised in month two. Now you will not be.
Want your exact number instead of an estimate?
Check Embody’s first-month offerHow Do Online GLP-1 Programs Work?
Every legitimate program on this page follows the same five steps: an online health questionnaire, review by a licensed clinician, a real prescription if you qualify, home delivery, and ongoing dose management. Start to first shipment typically takes under two weeks, and no in-person visit or referral is required for cash-pay programs.
Complete an online health questionnaire.
5–10 minutes: weight, height, health history, medications, goals.
A licensed clinician reviews your information.
Some programs review asynchronously; others schedule a short video visit. Embody’s FAQ says review typically happens within 24 hours.
If approved, a prescription is written.
A real prescription from a licensed provider — never an automated approval. Programs that guarantee approval are a red flag.
Medication ships to your door.
Typically 3–7 business days; Embody advertises fast, temperature-controlled, discreet delivery if prescribed.
Ongoing support and dose adjustments.
Your clinician adjusts your dose as you titrate up, usually via messaging or scheduled check-ins.
Follow-up care matters more than people realize. GLP-1 treatment is not one-and-done — you will need dose adjustments, side-effect help, and eventually a maintenance conversation. Support depth ranges from 24/7 messaging (Embody, MEDVi) to multi-day response times at budget programs. If you feel sick after a dose increase at 10pm, do you want to reach someone right away? Let that answer pick your program.
Do You Qualify for a GLP-1 Online Program?
Standard eligibility, based on FDA labeling for Wegovy and Zepbound: a BMI of 30 or higher, or a BMI of 27+ with at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, sleep apnea, or PCOS — and age 18 or older. A licensed clinician makes the final call in every case.
Who should not use GLP-1 medications (per FDA prescribing information):
Billing models vary — some programs charge an intake fee regardless of outcome; Embody’s stated policy is a full refund if the provider disqualifies you for a medical reason. Not sure where you land? Take the free 60-second matching quiz — four questions, no email, a clear recommendation.
How Much Weight Can You Realistically Lose?
In clinical trials of brand-name medications at full doses, semaglutide (Wegovy) produced about 15% average body-weight loss over 68 weeks and tirzepatide (Zepbound) about 22.5% over 72 weeks. Real-world results tend to come in somewhat lower, and individual response varies widely.
| Medication | Trial result (average) | Duration |
|---|---|---|
| Semaglutide 2.4 mg (Wegovy injection) | ~15% body weight loss | 68 weeks (STEP 1) |
| Tirzepatide 15 mg (Zepbound) | ~22.5% body weight loss | 72 weeks (SURMOUNT-1) |
| Head-to-head (SURMOUNT-5) | Tirzepatide 20.2% vs. semaglutide 13.7% | 72 weeks |
These numbers come from controlled trials using brand-name medications with close monitoring. The medications are effective — the variables are adherence, dosing, and which support system fits your life.
GLP-1 Side Effects: What to Expect
The most common side effects are nausea, constipation, diarrhea, stomach pain, headache, and fatigue — usually worst in the first weeks and at dose increases, and typically improving as your body adjusts.
How to manage the common stuff: start low and titrate slowly, eat smaller protein-forward meals, stay hydrated, and skip greasy food during titration. If nausea persists, ask your clinician about slowing the schedule — that is exactly what 24/7 messaging is for.
Serious but rare (per FDA labeling): severe abdominal pain (possible pancreatitis — stop and seek care), allergic reactions, gallbladder problems, vision changes. All GLP-1 prescribing information carries a boxed warning about thyroid C-cell tumors seen in animal studies — anyone with a personal or family history of MTC or MEN2 should not use these medications. Side effects are the reason every program on this page includes clinician access.
Will Insurance Cover Any of This?
Insurance sometimes covers brand-name GLP-1s (with prior authorization), almost never covers compounded products, and Medicare’s GLP-1 Bridge program begins July 1, 2026 with a $50 monthly copay for eligible Part D beneficiaries.
Brand-name coverage depends on your plan, diagnosis, and medication. Prior authorization, step therapy, and quantity limits create friction even when a drug is on formulary. This is the exact problem Ro’s insurance concierge exists to solve — run Ro’s free GLP-1 Coverage Checker before assuming anything about your plan.
Medicare: The Medicare GLP-1 Bridge begins July 1, 2026 and runs through December 31, 2027, covering Foundayo, Wegovy injection/tablets, and Zepbound KwikPen for eligible Part D beneficiaries at a flat $50 monthly copay. Compounded programs (including Embody) do not participate in Medicare in any form.
Compounded products are generally not covered by any insurance. Embody is cash-pay by design, which is also why it has no prior-auth delays.
HSA/FSA: GLP-1 medications prescribed by a licensed clinician are generally eligible. Embody accepts HSA/FSA at checkout; verify with your plan administrator either way.
Are There Needle-Free GLP-1 Options Now? (Pills, Tablets, and Gum)
Yes — three of them, and this is the biggest change of 2026. FDA-approved oral Wegovy launched (from $149/month self-pay), Eli Lilly’s Foundayo tablets are available through Ro, and Embody introduced a compounded GLP-1 gum — the only gum format we have found anywhere. “I don’t want to inject myself” is no longer a reason to wait.
| Format | FDA status | Typical cost | Where on this list |
|---|---|---|---|
| Oral Wegovy (semaglutide tablets) | FDA-approved | From $149/mo self-pay | Ro; Hims/Hers (verify availability) |
| Foundayo (orforglipron tablets) | FDA-approved | Manufacturer pricing — verify | Ro |
| GLP-1 gum (compounded semaglutide or tirzepatide) | Not FDA-approved (compounded) | $149 first month, then $349/mo (sema); $199 then $449/mo (tirz) | Embody only |
| Compounded tablets (semaglutide) | Not FDA-approved (compounded) | Verify on site | Willow; MEDVi |
The distinction matters: FDA-approved oral Wegovy and Foundayo went through full regulatory review. The gum and compounded tablets did not — they are legal compounded products, not approved drugs. Pick by what you value. Want the FDA-approved pill? Ro. Want the cheapest needle-free start, one minty piece a day? That is the gum. Check GLP-1 gum availability — Embody confirms your state and eligibility during a short intake.
Is Compounded Semaglutide Legitimate?
Compounded semaglutide is legal when prepared by a licensed compounding pharmacy under a valid prescription, and it is regulated under Sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act. It is not, however, FDA-approved — the agency does not review compounded drugs for safety, effectiveness, or quality before marketing, and they are not generics.
The FDA’s own guidance says compounded drugs should be used when a patient’s clinical needs cannot be met by an FDA-approved product, and the agency has warned that some products marketed as “semaglutide” use salt forms that differ from the approved active ingredient. If you choose the compounded route, ask two questions: which pharmacy prepares the medication, and what quality standards does it follow? Embody answers the first publicly — U.S.-based 503A pharmacies — and legitimate providers will always answer both.
What Happens If You Stop, Cancel, or Switch?
If you stop: the STEP 1 extension data showed participants regained a significant portion of lost weight within a year of stopping. That does not mean the medication “didn’t work” — GLP-1s manage appetite signals while you take them, like blood-pressure medication manages blood pressure. The best programs build sustainable habits alongside the medication.
If you cancel: most programs here are month-to-month. Embody and most others require notice before the next billing date (MEDVi: at least 72 hours), and medication already prescribed or shipped generally is not refunded. Read the cancellation terms — we flag the key ones in each review above.
If you switch: you can, anytime. You will complete a new intake with the new provider, since each platform uses its own clinician network and pharmacy. Plan for a short gap between providers.
How Do You Know a GLP-1 Provider Is Legitimate?
What We Actually Verified (June 2026)
Verified June 11–12, 2026:
- Embody’s Start Program pricing (Terms of Service): $99/$149/$149/$199 first month; $299–$449/month refills; Flat Program from $199/month
- Embody’s Trustpilot profile: 82 reviews, 3.1/5 — and that its on-site “4.8” badge does not match that independent score
- Embody’s refund-if-disqualified policy and its FAQ’s state exclusions (Mississippi, Louisiana)
- MEDVi’s pricing ($179 → $299/month compounded), its 11,498-review / 4.4 Trustpilot profile, and its February 20, 2026 FDA warning letter
- The FDA’s March 3, 2026 announcement of 30 warning letters and which listed providers on this page appeared in published letters
- Ro’s membership pricing ($39 → $149/month; as low as $74/month annual) and branded formulary
- Novo Nordisk’s oral Wegovy self-pay pricing tiers and the CMS Medicare GLP-1 Bridge start date (July 1, 2026)
Last full verification June 12, 2026 · Next scheduled review July 2026
How We Ranked and Verified These Providers
We evaluated 30+ programs against seven criteria, selected eight, and we do not list every program that offers an affiliate partnership. Rankings are editorial conclusions built on the verified facts above — and when the facts change, the rankings change (this page’s #1 changed in June 2026 for exactly that reason).
Pricing transparency — Is the all-in cost clearly stated, including post-promo and higher-dose rates?
Medication-type clarity — Brand-name vs. compounded clearly labeled, no implied equivalence?
Clinical oversight — Licensed U.S. clinicians and meaningful follow-up care?
Pharmacy sourcing — Partner pharmacies named or verifiable?
Third-party trust signals — Independent review profile and regulatory standing, weighed honestly (volume and score and recency)
Support accessibility — 24/7, business hours, or messaging-only?
Cancellation and refund terms — Month-to-month? What are the actual mechanics?
We check pricing, pharmacy status, regulatory standing, and review scores monthly. Last full verification: June 12, 2026.
Affiliate disclosure (in full): We earn commissions when you sign up through some links on this page. This does not affect our scoring, rankings, or analysis — the tradeoffs sections above, including the honest limitations of our #1 pick, are the proof. We have declined to feature providers that offered partnerships but did not meet our standards.
Frequently Asked Questions
What is the best GLP-1 online program right now?
For most self-pay users open to compounded medication, Embody is the strongest starting point in 2026 — lowest first month ($99), the only needle-free gum option, 24/7 support, and a refund if you do not medically qualify. For FDA-approved brand-name medication or insurance help, Ro leads. For the largest review track record, MEDVi.
Is Embody legit?
Embody is operated by Modern Metabolic Medicine, Inc., uses U.S.-licensed clinicians and U.S.-based 503A compounding pharmacies, requires a real prescription, and refunds patients a provider disqualifies for medical reasons. It is a newer program with a small public review base (82 Trustpilot reviews as of June 2026), and its shipped medications are compounded, not FDA-approved.
What is GLP-1 gum?
GLP-1 gum is a compounded form of semaglutide or tirzepatide taken as one piece of gum daily instead of a weekly injection, prescribed by a licensed clinician when appropriate. Embody is the only provider on our list offering it ($149 first month for semaglutide gum, then $349/month). It is not FDA-approved and is not the same product as oral Wegovy.
How much does Embody cost after the first month?
Standard refill pricing is $299/month for semaglutide injection, $349 for semaglutide gum, $399 for tirzepatide injection, and $449 for tirzepatide gum. Embody also lists flat-pricing plans from $199/month for semaglutide injection.
Is compounded semaglutide the same as Wegovy?
No. Compounded semaglutide is not FDA-approved and has not been reviewed by the FDA for safety, effectiveness, or quality. It is not the same as Wegovy or any FDA-approved product, and it is not equivalent to a generic drug.
Are compounded GLP-1 medications legal?
Yes, when prepared by a licensed compounding pharmacy under a valid prescription from a licensed clinician. They remain not-FDA-approved, and the FDA actively polices misleading marketing about them.
Can you get Wegovy online?
Yes. Ro carries Wegovy pill and pen at manufacturer-matched self-pay prices and can help with insurance coverage. Hims and Hers offer branded Wegovy through their Novo Nordisk collaboration. MEDVi currently lists Wegovy paths — verify pricing and availability before checkout.
Can you get Zepbound online?
Yes. Ro carries Zepbound pen and Zepbound KwikPen, and some other telehealth programs prescribe it. Availability and insurance coverage vary.
How much does a GLP-1 program cost per month?
Compounded programs on this list run $99–$449 per month depending on medication, format, and intro vs. ongoing pricing. Brand-name varies widely: oral Wegovy starts at $149/month self-pay at lower doses, and injectable brand-name products at higher doses cost significantly more.
Do I need insurance?
No. Embody, MEDVi, TrimRx, SkinnyRx, and Willow are built for cash-pay users. If you have insurance worth checking, Ro's free coverage checker answers that question at no cost.
Can I use HSA or FSA funds?
Generally yes for prescribed GLP-1 treatment. Embody accepts HSA/FSA at checkout. Verify with your plan administrator.
Will Medicare cover GLP-1s for weight loss?
Starting July 1, 2026, the Medicare GLP-1 Bridge covers Foundayo, Wegovy injection/tablets, and Zepbound KwikPen for eligible Part D beneficiaries at a $50 monthly copay, through December 31, 2027. Compounded programs do not participate in Medicare.
How quickly will I see results?
Clinical trials measured weight loss over 68–72 weeks. Individual timelines vary by medication, dose, adherence, and biology — judge progress in months, not weeks.
What happens if I stop taking GLP-1 medication?
Weight regain is common if sustainable habits are not in place; trial-extension data showed participants regained a significant portion of lost weight within a year of stopping. Discuss a maintenance plan with your clinician before stopping.
Is tirzepatide better than semaglutide for weight loss?
In a head-to-head trial, tirzepatide produced greater average weight loss — 20.2% vs. 13.7%. Individual response varies, and tirzepatide programs cost more (at Embody: $149 first month, then $399/month for injection).
What is a 503A vs 503B pharmacy?
A 503A pharmacy compounds individual prescriptions under state-board regulation; a 503B outsourcing facility produces larger batches under additional FDA oversight. Both are legal compounding routes. Embody's FAQ says its prescriptions are dispensed by U.S.-based 503A pharmacies.
Can I take GLP-1 medication if I have PCOS?
GLP-1 medications are often prescribed to women with PCOS who meet BMI criteria, and clinical evidence for PCOS-related weight management is growing. Discuss your specific situation with a clinician — PCOS counts as a qualifying weight-related condition at BMI 27+.
What is the difference between semaglutide and tirzepatide?
Semaglutide (the active ingredient in Wegovy and Ozempic) works on the GLP-1 receptor. Tirzepatide (in Zepbound and Mounjaro) works on both GLP-1 and GIP receptors, which is why it showed greater average weight loss in trials. Both are effective; a clinician recommends based on your health profile, goals, and budget.
Ready to Choose? Here Is Your Next Step
If you have read this far, you probably already know which path fits. Every program below starts with a short health intake — a few minutes of your time, a licensed clinician’s decision, and no commitment from checking.
If you want the lowest-cost start or the needle-free gum:
Check Embody Eligibility →$99 first month for semaglutide injection · full refund if you do not medically qualify
If you want FDA-approved brand-name medication or insurance help:
$39 to start · free coverage checker · concierge handles prior auth
If the biggest review track record matters most:
Check MEDVi pricing and availability11,498 Trustpilot reviews and counting
If you want a mainstream brand platform:
If you want a daily compounded tablet:
Explore Willow’s oral optionsIf budget is the only priority:
Billing models vary by provider. Verify current payment terms on each provider’s site before checkout.
Still Not Sure Which GLP-1 Program Is Right for You?
Take our free 60-second matching quiz. Answer four quick questions about your budget, medication preferences, insurance status, and priorities — and we will match you to the program that fits your situation. No email required. No sales pitch.
Over 30 programs evaluated · 8 recommended · One quiz to find yours
Find My PathNo signup required. No email needed to see your match. A licensed clinician makes all treatment decisions.
Sources
- Embody — Program details, pricing, and FAQ. joinem.co
- Embody — Terms & Conditions (Start and Flat Program pricing). joinem.co/pages/terms-conditions
- Embody — Refund Policy. joinem.co/pages/refund-policy
- Trustpilot — Embody reviews. trustpilot.com/review/joinem.co
- Trustpilot — MEDVi reviews. trustpilot.com/review/medvi.org
- FDA — FDA Warns 30 Telehealth Companies Against Illegal Marketing of Compounded GLP-1s. Press release, March 3, 2026. fda.gov
- FDA — Warning letter to MEDVi LLC, February 20, 2026. fda.gov
- FDA — Wegovy (semaglutide injection and tablets) Prescribing Information. fda.gov
- FDA — Zepbound (tirzepatide injection) Prescribing Information. fda.gov
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). NEJM, 2021.
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). NEJM, 2022.
- Tirzepatide versus Semaglutide for Weight Loss (SURMOUNT-5). NEJM, 2025.
- CMS — Medicare GLP-1 Bridge program and BALANCE Model. cms.gov
- Novo Nordisk — Wegovy self-pay pricing and Hims & Hers collaboration, March 2026. wegovy.com / novonordisk.com
- Ro — GLP-1 pricing, formulary, and insurance tools. ro.co
This content is for informational and educational purposes only and does not constitute medical advice. GLP-1 medications are prescription drugs that require evaluation by a licensed healthcare provider. Compounded GLP-1 products are not FDA-approved as finished medications and are not the same as generic drugs. Individual results vary. Always consult a qualified healthcare provider before starting any medication or weight-loss program.
Related Articles
Month-to-Month GLP-1 Providers
8 month-to-month GLP-1 providers compared on real prices, membership fees, billing cadence, and cancellation rules — with True Year Cost calculations.
GLP-1 Providers That Prescribe Wegovy and Zepbound
Verified 2026 matrix of GLP-1 telehealth providers carrying both brand-name Wegovy and Zepbound — Ro, Sesame, Walgreens, Hims & Hers, WW Med+, and more. Real prices, insurance/PA support, and the right route for your situation.
Wegovy HD vs Wegovy Pill
Wegovy HD averaged 18.8% weight loss vs 13.6% for the pill — but HD costs $100/mo more and you cannot start on it. Full 2026 comparison with verified prices, switching rules, and who each form actually fits.
GLP-1 Providers With Free Consultation
Which GLP-1 providers actually charge $0 for consultations? We verified 10+ providers. See real pricing, charge timing, and hidden fees. Updated April 2026.
GLP-1 Without Blood Work
Which GLP-1 providers require blood work? We verified 6 lab policies, prices, and refill rules — plus when skipping labs is a mistake. Updated April 2026.
GLP-1 Telehealth Local Pharmacy Pickup
7 verified GLP-1 telehealth options that route prescriptions to a local pharmacy — Sesame, GoodRx, Walgreens, Ro, PlushCare, Eden, Call-On-Doc. Real fees, same-day options, and insurance routes. April 2026.